Emmis Acquisition Corp. Class A Company Profile
NASDAQ: EMISHealth CareBiotechnology: Pharmaceutical PreparationsUSD
10.270.00 (0.00%)
At close: Sep 25, 4:00 PM ET · Delayed 15 min
Emmis Acquisition at a glance
Emmis Acquisition Corp. Class A (NASDAQ: EMIS) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector. The company's shares have traded publicly since 2025. At a market capitalization of $162.0 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0002075816, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Emmis Acquisition Corp. Class A
- Ticker
- NASDAQ: EMIS
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- United States
- IPO year
- 2025
- Market cap
- $162.02M
- SEC CIK
- 0002075816
Companies similar to Emmis Acquisition
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MSLESatellos Bioscience Inc. | 7.63 | +1.19% | $161.88M | vs EMIS |
| NKTXNkarta Inc. | 2.27 | -1.73% | $162.59M | vs EMIS |
| CUECue Biopharma Inc. | 22.51 | -2.72% | $163.52M | vs EMIS |
| NBPNovaBridge Biosciences ADR | 1.37 | -2.14% | $158.92M | vs EMIS |
| PEPGPepGen Inc. | 2.40 | +3.90% | $166.01M | vs EMIS |
| MENSJyong Biotech Ltd. | 2.06 | +1.98% | $156.62M | vs EMIS |
| ALXOALX Oncology Holdings Inc. | 1.13 | +1.80% | $156.25M | vs EMIS |
| NERVMinerva Neurosciences Inc | 3.27 | -4.66% | $156.13M | vs EMIS |